Live Breaking News & Updates on Aiims chief

Stay informed with the latest breaking news from Aiims chief on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Aiims chief and stay connected to the pulse of your community

"UK Government Not Accepting Vaccine Invented In UK": AIIMS Chief To NDTV

AIIMS chief Dr Randeep Guleria has criticised the UK government for its quarantine rules for people visiting Britain from India. "The UK government is not accepting a vaccine invented in the UK… Britain's norms for Indian nationals are peculiar. They seem to lack scientific basis," Dr Guleria said.

United-kingdom , Dr-randeep-guleria , Aiims-chief , Coronavirus , Covid-19 , Covid-19-cases-in-india , Covid-19-cases , Uk-government , Covid-vaccine , Covishield ,

No evidence that next wave will hit children: AIIMS director Dr Randeep Guleria | Delhi News

There is no evidence to suggest that the next wave of Covid-19 will cause serious infection in children, AIIMS director Dr Randeep Guleria said underl

Randeep-guleria , Delhi-news , Elhi-latest-news , Elhi-news-live , Elhi-news-today , Oday-news-delhi , Third-wave , Kids , Guleria , Data , Children-covid

Covid-19 | Mucormycosis is not a communicable disease, says AIIMS chief

Early detection, hygiene key to tackling condition, Randeep Guleria says.

India , Randeep-guleria , Health-ministry-lav-aggarwal , India-institute-of-medical-sciences , Health-ministry , All-india-institute , Medical-sciences , Coronavirus , Covid19 , Second-wave , Press-conference , Aiims-chief

'Remdesivir isn't a magic bullet': AIIMS chief on drug's use to treat Covid-19

'Remdesivir isn't a magic bullet': AIIMS chief on drug's use to treat Covid-19
Premium
(ANI)
Share Via
Read Full Story
As India reels under the massive surge of Covid-19 cases in the second wave of the pandemic, the All India Institute of Medical Sciences (AIIMS) Delhi director Dr Randeep Guleria highlighted some pertinent points of Covid management in the country.
In an interview, AIIMS chief spoke at length about the treatment of Covid-19 through drugs, steroids and CT scans.
TRENDING STORIESSee All
3 min read
Premium
2 min read
Premium
1 min read
Premium
1 min read
. 08:41 AM IST
Highlighting the usage of the anti-viral drug Remdesivir, Guleria informed, "It's important to understand that Remdesivir isn't magic bullet and isn't a drug that decreases mortality. We may use it as we don't have an anti-viral drug. It's of no use if given early to asymptomatic individuals/ones with mild symptoms. Also of no use, if given late," according to news agency

Randeep-guleria , Remdesivir , Aiims , Aiims-chief , Remdesivir-usage , Remdesivir-drug , Shortage-of-remdesivir , ரந்தீப்-குலேரியா , அய்ய்ம்ஸ் , அய்ய்ம்ஸ்-தலைமை ,

'Situation may completely get out of control if…': AIIMS chief issues warning amid Covid-19 surge

Updated Apr 12, 2021 | 17:27 IST
AIIMS Director Dr Randeep Guleria said the rate of spread of the Covid-19 infection is fast this time possibly due to the highly infectious and transmissible strains that are circulating.
AIIMS Director Dr Randeep Guleria | Photo Credit: ANI
Key Highlights
Dr Randeep Guleria calls for stricter enforcement of Covid guidelines
He also urges the people to get vaccinated against Covid-19
New Delhi: AIIMS Director Dr Randeep Guleria on Monday expressed concern over the fact that people had started to take Covid-19 lightly when highly infectious and transmissible strains of the coronavirus are circulating in the country. He said if the people fail to follow Covid-19 guidelines, the situation may get out of control.

South-africa , India , United-kingdom , New-delhi , Delhi , Brazil , Randeep-guleria , India-institute-of-medical-sciences , Photo-credit , All-india-institute , Medical-sciences , Co-vid

PM Modi's move to get inoculated would instil confidence among people, remove hesitancy: AIIMS chief

PM Modi's move to get inoculated would instil confidence among people, remove hesitancy: AIIMS chief
India
Published: Monday, March 1, 2021, 13:02 [IST]
New Delhi, Mar 01: Prime Minister Narendra Modi's move to take the first dose of COVID-19 vaccine on the very first day of India opening up the inoculation drive for senior citizens and those aged 45 and above with comorbidities should eliminate any hesitancy from the minds of people about the vaccine, AIIMS chief Dr Randeep Guleria said on Monday.
PM Modi chats with AIIMS nurses | What did he say | Oneindia News
Modi received the indigenously developed Covaxin jab by Bharat Biotech on Monday morning.

India , Puducherry , Pondicherry , New-delhi , Delhi , Bharat , Narendra-modi , Randeep-guleria , Madhuri-adnal , Simran-kashyap , Aarogya-setu , Remarkable

Azim Premji, Anand Mahindra, AIIMS Chief call for private participation in India's COVID-19 vaccine rollout

Azim Premji, Anand Mahindra, AIIMS Chief call for private participation in India’s COVID-19 vaccine rollout
Azim Premji, Anand Mahindra, AIIMS Chief call for private participation in India’s COVID-19 vaccine rollout
BI India/BCCL
In a closed door meeting with Finance Minister Nirmala Sitharaman, Premji reportedly pitched a plan to deliver the
COVID-19 vaccine to 500 million people within 60 days.
Earlier, Mahindra group chairman
Anand Mahindra had called for the participation of private players to boost the vaccination drive in India.
India has administered over 1.11 million doses of its approved vaccines 'Covishield' and 'Covaxin'.India is currently in the middle of the world’s largest COVID-19 vaccine rollout and to speed things up private participation might soon be important.

India , Nirmala-sitharaman , Azim-premji , Randeep-guleria , Adar-poonawalla , Anand-mahindra , Serum-institute-of-india , India-institute-of-medical-sciences , Finance-minister-nirmala-sitharaman , All-india-institute , Medical-sciences , Serum-institute

Indian Strains Of COVID Could Be More Infectious: AIIMS Chief

Indian Strains of COVID Could Be More Infectious: AIIMS Chief
Dr Randeep Guleria added that the new strain is “highly transmissible and dangerous” and could cause re-infections.
Comments
As reports of a new strain of coronavirus in Maharashtra emerge, AIIMS Chief, Dr Randeep Guleria on Saturday, 20 February, told
NDTV that herd immunity, especially in the case of the new Indian strains – found in Amravati and Akola – is a “myth” because at least 80 percent of the population needs to have developed anti-bodies to fight the virus.
The doctor added that the new strain is “highly transmissible and dangerous” and could cause re-infections for those who have previously developed anti-bodies. Guleria attributed the re-infections to “immune escape mechanism” of variants of the virus.

Randeep-guleria , Indian-strains , Aiims , Aiims-chief , Covid-task-force , Covid-19 , Covid-19-updates , Maharashtra-covid-19 , Maharashtra-covid-updates , New-strain , New-covid-strain-india

Top news of the day, February 20, 2021

“We recently liberalised geospatial data. If we could have done this 10 years back, it is likely that Google would have been made in India, not outside. The talent is Indian but the product is not,” he said at the sixth meeting of the Governing Council of NITI Aayog.
A Bench headed by the environment watchdog’s Chairperson, Justice A.K. Goel, said it
prima facie agreed that OIL failed to take safety precautions and there was need for ensuring such incidents do not recur.

Madhya-pradesh , India , Australia , Maldives , China , Beijing , Tanden , Arunachal-pradesh , Delhi , Chhattisgarh , Kremlin , Moskva

Should You Send Your Child Back To School Amid Covid? AIIMS Chief Answers

After a 10-month hiatus due to COVID-19, schools are reopening across the country and parents are facing a dilemma - Should they send their children to school or not? Now or later? How should they evaluate the pros and cons? AIIMS Director Randeep Guleria answers questions on schools reopening amid the pandemic.

Randeep-guleria , Dr-randeep-guleria , Aiims-chief , Covid-19-cases , Schools-reopening , Dr-gulerai-on-schools-reopening , ரந்தீப்-குலேரியா , டாக்டர்-ரந்தீப்-குலேரியா , அய்ய்ம்ஸ்-தலைமை , பள்ளிகள்-மீண்டும்-திறக்கிறது ,